Enveric Biosciences, Inc. (ENVB) earnings
ENVB earnings moved a median of -3.31% by the close. Quarterly and annual ENVB reports and results, each read against the price at its own news timestamp. Back to the ENVB overview →
21 measured ENVB earnings events.
Where these ENVB earnings landedvs 21 measured ENVB earnings reactions
| Middle 50% of ENVB earnings reactions | -4.25% to -0.90% |
|---|---|
| Median reaction (to close) | -3.31% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 ENVB earnings events with a measured close landed between -4.25% and -0.90%; 19% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 | Press release | -3.90% | -3.90% | |
| Form 10-Q Enveric Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -3.90% | -3.90% | |
| Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026 | Press release | -0.44% | +0.45% | |
| Form 10-Q Enveric Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -0.44% | +0.45% | |
| Form 10-K Enveric Biosciences, For: Dec 31 | SEC filing · Form 10-K | -0.55% | -1.65% | |
| Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results | Press release | -0.95% | -5.33% | |
| Form 10-Q Enveric Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -0.95% | -5.33% | |
| Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results | Press release | +0.00% | +0.00% | |
| Form 10-Q Enveric Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -1.35% | -0.90% | |
| Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results | Press release | -3.77% | -3.82% | |
| Form 10-Q Enveric Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -3.77% | -3.82% | |
| Form 10-K Enveric Biosciences, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.42% | |
| Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results | Press release | +2.86% | -4.25% | |
| Form 10-Q Enveric Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +2.86% | -4.25% | |
| Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results | Press release | +1.27% | -5.05% | |
| Form 10-Q Enveric Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +1.27% | -5.05% | |
| Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results | Press release | -0.86% | -3.31% | |
| Form 10-Q Enveric Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -0.86% | -3.31% | |
| Form 10-K Enveric Biosciences, For: Dec 31 | SEC filing · Form 10-K | -2.36% | -0.94% | |
| Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results | Press release | +0.00% | +1.35% | |
| Form 10-Q Enveric Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.35% |
Keep exploring
More ENVB: analyst actions → · SEC filings → · ENVB overview →